Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Journal of Shanghai Jiaotong University(Medical Science) ; (12): 1707-1709, 2017.
Article in Chinese | WPRIM | ID: wpr-665313

ABSTRACT

Retinoblastoma (RB) is one of the most common primary intraocular malignant tumors of children. With improvement of the medical care, the goal of RB treatment is saving the eyeball and even the vision. In the process of globe-salvaging treatment, complicated cataract has been a serious problem which affects the treatment and follow-up. It is important to operate a cataract surgery timely and safely. In this paper related research advances were summarized.

2.
Acta Pharmaceutica Sinica ; (12): 621-634, 2013.
Article in Chinese | WPRIM | ID: wpr-235618

ABSTRACT

Based on the character of the molecular structure, the prodrugs of phosphates and phosphonates were divided into two categories. The first is the drug which contained the phosphate group, introducing protected groups to increase lipophilicity and improve bioavailability. The other one is the drug which had no phosphate group, introducing the phosphate group into molecules to enhance the solubility, regulate the distribution coefficient and enhance the drug-like property. This review focuses on the application of phosphates and phosphonates in drug research and development based on improvement of physico-chemical property, drug safety and the pharmacokinetics.


Subject(s)
Animals , Humans , Biological Availability , Drug Design , Drug Stability , Molecular Structure , Organophosphonates , Chemistry , Pharmacokinetics , Phosphates , Chemistry , Pharmacokinetics , Prodrugs , Chemistry , Classification , Pharmacokinetics , Solubility , Structure-Activity Relationship , Tissue Distribution
3.
Acta Pharmaceutica Sinica ; (12): 621-34, 2013.
Article in Chinese | WPRIM | ID: wpr-445628

ABSTRACT

Based on the character of the molecular structure, the prodrugs of phosphates and phosphonates were divided into two categories. The first is the drug which contained the phosphate group, introducing protected groups to increase lipophilicity and improve bioavailability. The other one is the drug which had no phosphate group, introducing the phosphate group into molecules to enhance the solubility, regulate the distribution coefficient and enhance the drug-like property. This review focuses on the application of phosphates and phosphonates in drug research and development based on improvement of physico-chemical property, drug safety and the pharmacokinetics.

SELECTION OF CITATIONS
SEARCH DETAIL